Search

everythinglearnresearchcommunity

for

Search:↓

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

AI can help diagnose Follicular Lymphoma by accurately identifying specific cell types.

Colorectal cancer cells can adapt without losing their traits or drug sensitivity.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

OCT4 helps hair stem cells renew and fight aging, potentially aiding hair regrowth.

New mutations in the VDR gene cause vitamin D-resistant rickets without hair loss.

RCS-01 is safe and may help rejuvenate aging skin.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Low power red laser with efavirenz can reduce HIV-1 infection to undetectable levels and improve diagnosis.

Different markers are found in stem cells of the scalp's hair follicle bulge and the surrounding skin.

ALUDWIG can help standardize female hair loss assessment from a single image.

CXXC5 is a protein that controls cell growth and healing processes, and changes in its activity can lead to diseases like cancer and hair loss.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Dandelion-derived carbon dots effectively kill bacteria and speed up wound healing.

A specific gene mutation causes vitamin D resistance, but certain vitamin D analogs might help.

CD8+ virtual memory T cells may cause hair loss in alopecia areata.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

SKH1 hairless mice have identifiable epidermal stem cells with specific markers.

The Fas/FasL pathway may play a role in alopecia areata.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.